Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Conditions

• Pancreatic Cancer
• Pancreatic Cancer Non-resectable
• Pancreatic Ductal Adenocarcinoma, PDAC

Interventions

• DRUG: surufatinib combined with gemcitabine plus nab-paclitaxel

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology